Report Detail

Request for Sample of this report

Other Global (United States, European Union and China) Self-Monitoring Blood Glucose System Market Research Report 2019-2025

  • RnM3364317
    • |
  • 14 July, 2020
    • |
  • Global
    • |
  • 113 Pages
    • |
  • QYResearch
    • |
  • Other

Self-Monitoring Blood Glucose System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Self-Monitoring Blood Glucose System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Self-Monitoring Blood Glucose System market is segmented into
Blood Glucose meters
Testing strips
Lancets & Lancing Devices

Segment by Application, the Self-Monitoring Blood Glucose System market is segmented into
Type 2 Diabetes
Type 1 Diabetes
Gestational Diabetes

Regional and Country-level Analysis
The Self-Monitoring Blood Glucose System market is analysed and market size information is provided by regions (countries).
The key regions covered in the Self-Monitoring Blood Glucose System market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Self-Monitoring Blood Glucose System Market Share Analysis

Self-Monitoring Blood Glucose System market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Self-Monitoring Blood Glucose System by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Self-Monitoring Blood Glucose System business, the date to enter into the Self-Monitoring Blood Glucose System market, Self-Monitoring Blood Glucose System product introduction, recent developments, etc.
The major vendors covered:
Roche (Switzerland)
Abbott (US)
LifeScan (US)
Ascensia (Switzerland)
Medtronic (Ireland), Dexcom (US)
Ypsomed (Switzerland)
B. Braun (Germany)
Nipro (Japan), Sanofi (France)
ARKRAY (Japan)
Prodigy Diabetes Care (US)
ACON Laboratories (US)
Nova Biomedical (US)


1 Study Coverage

  • 1.1 Self-Monitoring Blood Glucose System Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Self-Monitoring Blood Glucose System Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Self-Monitoring Blood Glucose System Market Size Growth Rate by Type
    • 1.4.2 Blood Glucose meters
    • 1.4.3 Testing strips
    • 1.4.4 Lancets & Lancing Devices
  • 1.5 Market by Application
    • 1.5.1 Global Self-Monitoring Blood Glucose System Market Size Growth Rate by Application
    • 1.5.2 Type 2 Diabetes
    • 1.5.3 Type 1 Diabetes
    • 1.5.4 Gestational Diabetes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Self-Monitoring Blood Glucose System Market Size, Estimates and Forecasts
    • 2.1.1 Global Self-Monitoring Blood Glucose System Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Self-Monitoring Blood Glucose System Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Self-Monitoring Blood Glucose System Production Estimates and Forecasts 2015-2026
  • 2.2 Global Self-Monitoring Blood Glucose System, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Self-Monitoring Blood Glucose System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Self-Monitoring Blood Glucose System Manufacturers Geographical Distribution
  • 2.4 Key Trends for Self-Monitoring Blood Glucose System Markets & Products
  • 2.5 Primary Interviews with Key Self-Monitoring Blood Glucose System Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Self-Monitoring Blood Glucose System Manufacturers by Production Capacity
    • 3.1.1 Global Top Self-Monitoring Blood Glucose System Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Self-Monitoring Blood Glucose System Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Self-Monitoring Blood Glucose System Manufacturers Market Share by Production
  • 3.2 Global Top Self-Monitoring Blood Glucose System Manufacturers by Revenue
    • 3.2.1 Global Top Self-Monitoring Blood Glucose System Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Self-Monitoring Blood Glucose System Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Self-Monitoring Blood Glucose System Revenue in 2019
  • 3.3 Global Self-Monitoring Blood Glucose System Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Self-Monitoring Blood Glucose System Production by Regions

  • 4.1 Global Self-Monitoring Blood Glucose System Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Self-Monitoring Blood Glucose System Regions by Production (2015-2020)
    • 4.1.2 Global Top Self-Monitoring Blood Glucose System Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Self-Monitoring Blood Glucose System Production (2015-2020)
    • 4.2.2 North America Self-Monitoring Blood Glucose System Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Self-Monitoring Blood Glucose System Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Self-Monitoring Blood Glucose System Production (2015-2020)
    • 4.3.2 Europe Self-Monitoring Blood Glucose System Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Self-Monitoring Blood Glucose System Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Self-Monitoring Blood Glucose System Production (2015-2020)
    • 4.4.2 China Self-Monitoring Blood Glucose System Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Self-Monitoring Blood Glucose System Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Self-Monitoring Blood Glucose System Production (2015-2020)
    • 4.5.2 Japan Self-Monitoring Blood Glucose System Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Self-Monitoring Blood Glucose System Import & Export (2015-2020)

5 Self-Monitoring Blood Glucose System Consumption by Region

  • 5.1 Global Top Self-Monitoring Blood Glucose System Regions by Consumption
    • 5.1.1 Global Top Self-Monitoring Blood Glucose System Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Self-Monitoring Blood Glucose System Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Self-Monitoring Blood Glucose System Consumption by Application
    • 5.2.2 North America Self-Monitoring Blood Glucose System Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Self-Monitoring Blood Glucose System Consumption by Application
    • 5.3.2 Europe Self-Monitoring Blood Glucose System Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Self-Monitoring Blood Glucose System Consumption by Application
    • 5.4.2 Asia Pacific Self-Monitoring Blood Glucose System Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Self-Monitoring Blood Glucose System Consumption by Application
    • 5.5.2 Central & South America Self-Monitoring Blood Glucose System Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Self-Monitoring Blood Glucose System Consumption by Application
    • 5.6.2 Middle East and Africa Self-Monitoring Blood Glucose System Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Self-Monitoring Blood Glucose System Market Size by Type (2015-2020)
    • 6.1.1 Global Self-Monitoring Blood Glucose System Production by Type (2015-2020)
    • 6.1.2 Global Self-Monitoring Blood Glucose System Revenue by Type (2015-2020)
    • 6.1.3 Self-Monitoring Blood Glucose System Price by Type (2015-2020)
  • 6.2 Global Self-Monitoring Blood Glucose System Market Forecast by Type (2021-2026)
    • 6.2.1 Global Self-Monitoring Blood Glucose System Production Forecast by Type (2021-2026)
    • 6.2.2 Global Self-Monitoring Blood Glucose System Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Self-Monitoring Blood Glucose System Price Forecast by Type (2021-2026)
  • 6.3 Global Self-Monitoring Blood Glucose System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Self-Monitoring Blood Glucose System Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Self-Monitoring Blood Glucose System Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Roche (Switzerland)
    • 8.1.1 Roche (Switzerland) Corporation Information
    • 8.1.2 Roche (Switzerland) Overview
    • 8.1.3 Roche (Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Roche (Switzerland) Product Description
    • 8.1.5 Roche (Switzerland) Related Developments
  • 8.2 Abbott (US)
    • 8.2.1 Abbott (US) Corporation Information
    • 8.2.2 Abbott (US) Overview
    • 8.2.3 Abbott (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Abbott (US) Product Description
    • 8.2.5 Abbott (US) Related Developments
  • 8.3 LifeScan (US)
    • 8.3.1 LifeScan (US) Corporation Information
    • 8.3.2 LifeScan (US) Overview
    • 8.3.3 LifeScan (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 LifeScan (US) Product Description
    • 8.3.5 LifeScan (US) Related Developments
  • 8.4 Ascensia (Switzerland)
    • 8.4.1 Ascensia (Switzerland) Corporation Information
    • 8.4.2 Ascensia (Switzerland) Overview
    • 8.4.3 Ascensia (Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Ascensia (Switzerland) Product Description
    • 8.4.5 Ascensia (Switzerland) Related Developments
  • 8.5 Medtronic (Ireland), Dexcom (US)
    • 8.5.1 Medtronic (Ireland), Dexcom (US) Corporation Information
    • 8.5.2 Medtronic (Ireland), Dexcom (US) Overview
    • 8.5.3 Medtronic (Ireland), Dexcom (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Medtronic (Ireland), Dexcom (US) Product Description
    • 8.5.5 Medtronic (Ireland), Dexcom (US) Related Developments
  • 8.6 Ypsomed (Switzerland)
    • 8.6.1 Ypsomed (Switzerland) Corporation Information
    • 8.6.2 Ypsomed (Switzerland) Overview
    • 8.6.3 Ypsomed (Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Ypsomed (Switzerland) Product Description
    • 8.6.5 Ypsomed (Switzerland) Related Developments
  • 8.7 B. Braun (Germany)
    • 8.7.1 B. Braun (Germany) Corporation Information
    • 8.7.2 B. Braun (Germany) Overview
    • 8.7.3 B. Braun (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 B. Braun (Germany) Product Description
    • 8.7.5 B. Braun (Germany) Related Developments
  • 8.8 Nipro (Japan), Sanofi (France)
    • 8.8.1 Nipro (Japan), Sanofi (France) Corporation Information
    • 8.8.2 Nipro (Japan), Sanofi (France) Overview
    • 8.8.3 Nipro (Japan), Sanofi (France) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Nipro (Japan), Sanofi (France) Product Description
    • 8.8.5 Nipro (Japan), Sanofi (France) Related Developments
  • 8.9 ARKRAY (Japan)
    • 8.9.1 ARKRAY (Japan) Corporation Information
    • 8.9.2 ARKRAY (Japan) Overview
    • 8.9.3 ARKRAY (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 ARKRAY (Japan) Product Description
    • 8.9.5 ARKRAY (Japan) Related Developments
  • 8.10 Prodigy Diabetes Care (US)
    • 8.10.1 Prodigy Diabetes Care (US) Corporation Information
    • 8.10.2 Prodigy Diabetes Care (US) Overview
    • 8.10.3 Prodigy Diabetes Care (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Prodigy Diabetes Care (US) Product Description
    • 8.10.5 Prodigy Diabetes Care (US) Related Developments
  • 8.11 ACON Laboratories (US)
    • 8.11.1 ACON Laboratories (US) Corporation Information
    • 8.11.2 ACON Laboratories (US) Overview
    • 8.11.3 ACON Laboratories (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 ACON Laboratories (US) Product Description
    • 8.11.5 ACON Laboratories (US) Related Developments
  • 8.12 Nova Biomedical (US)
    • 8.12.1 Nova Biomedical (US) Corporation Information
    • 8.12.2 Nova Biomedical (US) Overview
    • 8.12.3 Nova Biomedical (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Nova Biomedical (US) Product Description
    • 8.12.5 Nova Biomedical (US) Related Developments

9 Self-Monitoring Blood Glucose System Production Forecast by Regions

  • 9.1 Global Top Self-Monitoring Blood Glucose System Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Self-Monitoring Blood Glucose System Regions Forecast by Production (2021-2026)
  • 9.3 Key Self-Monitoring Blood Glucose System Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Self-Monitoring Blood Glucose System Consumption Forecast by Region

  • 10.1 Global Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)
  • 10.2 North America Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Self-Monitoring Blood Glucose System Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Self-Monitoring Blood Glucose System Sales Channels
    • 11.2.2 Self-Monitoring Blood Glucose System Distributors
  • 11.3 Self-Monitoring Blood Glucose System Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Self-Monitoring Blood Glucose System Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Self-Monitoring Blood Glucose System Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Self-Monitoring Blood Glucose System Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Self-Monitoring Blood Glucose System. Industry analysis & Market Report on Self-Monitoring Blood Glucose System is a syndicated market report, published as Global (United States, European Union and China) Self-Monitoring Blood Glucose System Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Self-Monitoring Blood Glucose System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,900.00
    		$7,350.00
    		$9,800.00
    		3,861.20
    		5,791.80
    		7,722.40
    		4,508.00
    		6,762.00
    		9,016.00
    		763,371.00
    		1,145,056.50
    		1,526,742.00
    		408,464.00
    		612,696.00
    		816,928.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo